Correction Bone marrow MSCs in MDS contribution towards dysfunctional hematopoiesis and potential targets for disease response to hypomethylating therapy

Correction: Bone marrow MSCs in MDS: contribution towards dysfunctional hematopoiesis and potential targets for disease response to hypomethylating therapy

15:25 EST 20 Feb 2019 | Nature Publishing

More From BioPortfolio on "Correction: Bone marrow MSCs in MDS: contribution towards dysfunctional hematopoiesis and potential targets for disease response to hypomethylating therapy"